Table 1.

In Vitro Cytotoxicity of CRLX101 and CPT Against Multiple Human Cancer Cell Lines Determined by a 48 Hour MTS Assay

Cell Line	IC50 CPT [µM]	IC50 IT-101 [µM]
NCI-H1299 NSCLC	0.100	0.320
HT-29 Colorectal	0.020	0.218
A2780 Ovarian	0.007	0.039
PANC-1 Pancreatic	0.050	0.100
DAUDI Burkitt’s Lymphoma	0.060	0.170

IC₅₀: 50% inhibitory concentration. Data from T. Schluep (personal communication), references [7, 22].